A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin SignalingZachary A. Knight, Kevan M. Shokat, Balázs István Tóth et al.|Cell|2006Cited by 1.2k
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2Morris E. Feldman, Kevan M. Shokat, Beth Apsel et al.|PLoS Biology|2009Cited by 1.1k
T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTORStephan Sauer, Matthias Merkenschlager, Ludovica Bruno et al.|Proceedings of the National Academy of Sciences|2008Cited by 832
Targeting the cancer kinome through polypharmacologyZachary A. Knight, Kevan M. Shokat, Henry J. Lin|Nature reviews. Cancer|2010Cited by 683
Features of Selective Kinase InhibitorsZachary A. Knight, Kevan M. Shokat|Chemistry & Biology|2005Cited by 655